Recurrent monomorphic epitheliotropic intestinal T-cell lymphoma with aberrant CD20 expression: An implication for anti-CD20 (rituximab) antibody therapy?-Reference-Cited by-同舟云学术

Recurrent monomorphic epitheliotropic intestinal T-cell lymphoma with aberrant CD20 expression: An implication for anti-CD20 (rituximab) antibody therapy?

Published:2018-11-06 Issue:12 Volume:68 Page:712-714
ISSN:1320-5463
Container-title:Pathology International
language:en
Short-container-title:Pathol Int

Author:

Liao Pi-Han¹,Chou Shih-Cheng²,Huang Wan-Ting³,Su Ying-Zhen⁴,Wang Ming-Chung¹,Chuang Shih-Sung⁴^ORCID

Affiliation:

1. Division of Hematology-Oncology; Department of Internal Medicine; Kaohsiung-Chang Gung Memorial Hospital-Kaohsiung Medical Center; Kaohsiung Taiwan

2. Department of Pathology; Yuan's General Hospital; Kaohsiung Taiwan

3. Department of Pathology; Kaohsiung Chang Gung Memorial Hospital-Kaohsiung Medical Center; Kaohsiung and College of Medicine; Kaohsiung and Chang Gung University; Kaohsiung Taiwan

4. Department of Pathology; Chi-Mei Medical Center Tainan; Taiwan

Publisher

Wiley

Subject

General Medicine,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pin.12730/fullpdf

Reference5 articles.

1. Primary gastric extranodal natural killer/T-cell lymphoma, nasal type, with acquisition of CD20 expression in the subcutaneous relapse: report of a case with literature review;Huang;J Clin Pathol,2015

2. Peripheral T-cell lymphoma with aberrant expression of CD79a and CD20: A diagnostic pitfall;Yao;Mod Pathol,2001

3. CD20+ T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature;Rahemtullah;Am J Surg Pathol,2008

4. CD20 positive T-cell lymphoma/leukemia: A rare entity with potential diagnostic pitfalls;Buckner;Ann Clin Lab Sci,2007

5. Rituximab for the treatment of CD20-positive peripheral T-cell lymphoma, unspecified;Hirata;Leukemia Res,2009